Thomas A. West

Thomas West (Tom) has served as a Member of the Board since April 2023. He currently is President, CEO and Director of Nalu Medical, Inc., a venture-backed medical technology company focused on developing and commercializing innovative and minimally invasive neurostimulation solutions for patients with chronic neuropathic pain. Prior to Nalu, Mr. West served as President, CEO and Director of publicly traded Intersect ENT (Nasdaq: XENT), a sinus surgery innovator in the medical device and pharmaceutical space that was purchased by Medtronic in May 2022. Mr. West has over 30 years of medical technology experience including as Worldwide President, Diagnostic Solutions at Hologic from 2014 to 2019, and as President of LifeScan at Johnson & Johnson. He began his healthcare career at Johnson & Johnson in 1992 assuming roles of increasing responsibility and has directly led and supported businesses around the globe in medical devices, pharmaceuticals, and consumer healthcare.

He has a bachelor’s degree with honors in Politics and Economics from Princeton University and a Master of Business Administration from the University of Pennsylvania’s Wharton School.